Canada markets closed

ChemoCentryx, Inc. (CCXI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
36.28-2.60 (-6.69%)
At close: 1:00PM EST
38.49 +2.21 (+6.09%)
After hours: 04:55PM EST
Currency in USD

Valuation Measures

Market Cap (intraday) 52.74B
Enterprise Value 32.55B
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)80.65
Price/Book (mrq)8.69
Enterprise Value/Revenue 375.30
Enterprise Value/EBITDA 7-22.00

Trading Information

Stock Price History

Beta (5Y Monthly) 1.83
52-Week Change 3-29.50%
S&P500 52-Week Change 329.82%
52 Week High 370.29
52 Week Low 39.53
50-Day Moving Average 331.05
200-Day Moving Average 329.58

Share Statistics

Avg Vol (3 month) 34.97M
Avg Vol (10 day) 31.32M
Shares Outstanding 570.03M
Implied Shares Outstanding 6N/A
Float 857.76M
% Held by Insiders 117.57%
% Held by Institutions 164.14%
Shares Short (Nov. 14, 2021) 46.04M
Short Ratio (Nov. 14, 2021) 43.36
Short % of Float (Nov. 14, 2021) 412.75%
Short % of Shares Outstanding (Nov. 14, 2021) 48.63%
Shares Short (prior month Oct. 14, 2021) 45.48M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)-348.58%

Management Effectiveness

Return on Assets (ttm)-15.11%
Return on Equity (ttm)-33.61%

Income Statement

Revenue (ttm)34.27M
Revenue Per Share (ttm)0.49
Quarterly Revenue Growth (yoy)248.90%
Gross Profit (ttm)-12.99M
EBITDA -116.93M
Net Income Avi to Common (ttm)-121.1M
Diluted EPS (ttm)-1.74
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)269.43M
Total Cash Per Share (mrq)3.85
Total Debt (mrq)72.95M
Total Debt/Equity (mrq)23.09
Current Ratio (mrq)4.89
Book Value Per Share (mrq)4.52

Cash Flow Statement

Operating Cash Flow (ttm)-83.96M
Levered Free Cash Flow (ttm)-91.6M